Company News - Yuanshan Group (00551.HK) reported a cumulative operating income of approximately $6.017 billion for the first nine months, a decrease of 1% year-on-year [2] - Baoshan International (03813.HK) recorded a cumulative operating income of 12.903 billion yuan for the first nine months, down 7.7% year-on-year [2] - Longyuan Power (00916.HK) achieved a cumulative power generation of 56,546,706 MWh in the first nine months, a decline of 0.53% year-on-year; excluding the impact of thermal power, there was a year-on-year increase of 13.81%, with wind power up 5.30% and solar power up 77.98% [2] Financial Performance - Qinhuangdao Port Co., Ltd. (03369.HK) reported a total throughput of 317 million tons for the first nine months, an increase of 5.56% year-on-year [3] - New China Life Insurance (01336.HK) expects net profit attributable to shareholders for the first three quarters to be between 29.986 billion yuan and 34.122 billion yuan, representing a year-on-year growth of 45% to 65% [3] - Jiangshan Holdings (00295.HK) reported a total power generation of approximately 238,787 MWh for the first nine months, a decrease of 4.83% year-on-year [3] - Morning News Technology (02000.HK) reported an unaudited revenue of 270 million HKD for the first nine months, down 7.6% year-on-year [3] - Dekang Agriculture and Animal Husbandry (02419.HK) sold approximately 7.5509 million pigs in the first nine months, with sales revenue of approximately 14.277 billion yuan [3] Drug Approvals and Developments - Hengrui Medicine (01276.HK) received a clinical trial approval notice for SHR-A2102, a targeted Nectin-4 antibody-drug conjugate (ADC) developed in-house; global sales for similar products are expected to reach approximately $1.949 billion in 2024 according to EvaluatePharma [3] - Hutchison China MediTech (00013.HK) plans to announce FRUSICA-2 registration study data at the 2025 European Society for Medical Oncology annual meeting [3] - CSPC Pharmaceutical Group (01093.HK) had its new drug application for Idaglutide α injection accepted by the National Medical Products Administration [3] Corporate Actions - Huazhen Medical (01931.HK) announced the acquisition of U.S. properties and the establishment of a U.S. subsidiary, ETHK BANK, to promote stablecoins and intellectual property securitization in the U.S. [3] - Lihigh Holdings (08472.HK) plans to invest 24 million HKD in cryptocurrency and commodities [3] - Hisense Home Appliances (00921.HK) and its subsidiaries subscribed to a financial product from Jingu Trust worth 1.739 billion HKD [3] Real Estate Performance - New Town Development (01030.HK) reported cumulative contract sales of 15.050 billion yuan for the first nine months, a decrease of 52.72% year-on-year [3] - Longfor Group (00960.HK) achieved total contract sales of 50.75 billion yuan in the first nine months [3] - CIFI Holdings Group (00884.HK) reported cumulative contract sales of approximately 13.06 billion yuan for the first nine months [3] - Ronshine China Holdings (03301.HK) reported contract sales of 3 billion yuan for the first nine months, down 45.3% year-on-year [3] - Yuzhou Group (01628.HK) reported cumulative sales of 4.913 billion yuan for the first nine months [3] - Yida China (03639.HK) reported contract sales of approximately 572 million yuan for the first nine months, down 24.74% year-on-year [3] Financing and Buyback Activities - Geely Automobile (00175.HK) was approved to issue debt financing instruments totaling no more than 10 billion yuan [3] - HSBC Holdings (00005.HK) repurchased 1.58 million HKD worth of shares at prices ranging from 102.2 to 103.77 HKD [3] - Xiaomi Group-W (01810.HK) repurchased 400 million HKD worth of shares at prices ranging from 47.82 to 50.55 HKD [3] - Shoucheng Holdings (00697.HK) repurchased 890 million HKD worth of shares at prices ranging from 2.21 to 2.27 HKD [3]

Core Viewpoint - The company has approved a budget of HKD 24 million for purchasing cryptocurrencies and commodities over the next year, indicating a strategic move into the digital asset space [1] Group 1: Financial Commitment - The board has allocated HKD 24 million for the acquisition of cryptocurrencies and commodities [1] - The funding for these purchases will come from the company's internal cash resources [1] Group 2: Investment Focus - The company plans to invest in regulated and licensed trading platforms [1] - The targeted assets include Bitcoin (BTC), Ethereum (ETH), gold, and silver [1] Group 3: Market Strategy - The execution of these purchases will be based on market conditions [1]

Core Viewpoint - The company has approved a budget of HKD 24.0 million for purchasing cryptocurrencies and commodities over the next year, indicating a strategic move towards diversifying its investment portfolio in response to market conditions [1] Group 1: Investment Strategy - The budget will be utilized for acquiring cryptocurrencies such as Bitcoin (BTC) and Ethereum (ETH), as well as commodities like gold and silver [1] - The funding for these purchases will come from the company's internal cash resources, suggesting a strong liquidity position [1] Group 2: Market Outlook - The company expresses confidence in the long-term potential of cryptocurrencies and commodities, citing their ability to act as a hedge against inflation and their potential for appreciation [1] - The current market conditions are viewed as an opportune time for investment in these assets, reflecting a proactive approach to capitalizing on market trends [1] Group 3: Business Integration - The acquisition of cryptocurrencies is intended to complement the company's existing online gaming services, indicating a strategic alignment between its investment activities and core business operations [1]

Core Viewpoint - The company has approved a budget of HKD 24 million for purchasing cryptocurrencies and commodities over the next year, indicating a strategic move into the digital asset space [1] Group 1: Financial Commitment - The board has allocated a budget of HKD 24 million for the acquisition of cryptocurrencies and commodities [1] - The funding for these purchases will come from the company's internal cash resources [1] Group 2: Investment Focus - The company plans to invest in regulated and licensed trading platforms [1] - The targeted assets include Bitcoin (BTC), Ethereum (ETH), gold, and silver [1] Group 3: Market Strategy - The execution of these purchases will be based on market conditions, suggesting a flexible investment approach [1]

⽴⾼控股有限公司 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部 分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） Lapco Holdings Limited 本公司股東及潛在投資者請注意，本集團可能買賣的任何加密貨幣及商品將取決於市 場情況，並由董事會酌情決定。加密貨幣及商品市場在短期內可能動盪，而加密貨幣 及商品的價格亦可能存在波幅。因此，無法保證本集團買賣任何加密貨幣及商品的時 間、數量、類型或價格。本公司股東及潛在投資者於買賣本公司股份時務須審慎行事。 本公司將遵守香港聯合交易所有限公司GEM證券上市規則（「GEM 上市規則」）中有關 本集團買賣加密貨幣及商品的相關披露規定。 – 1 – 承董事會命 立高控股有限公司 執行董事 （股份代號：8472） 劉晶晶 自願性公告 擬購買加密貨幣及商品 本公告乃由立高控股有限公司（「本公司」，連同其附屬公司統稱「本集團」）自願 作出。 本公司董事會（「董事會」）謹此通知本公司股東及潛在投資者 ...

FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 立高控股有限公司（於開曼群島註冊成立的有限公司） 呈交日期: 2025年10月6日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 08472 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 500,000,000 | HKD | | 0.2 HKD | | 100,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 500,000,000 | HKD | | 0.2 HKD | | 100,000,000 | 本月底法定/註冊股本總 ...

Core Viewpoint - The company announced that its major shareholder, Mr. Tan Weitang, sold a total of 6.5 million shares through public market transactions, representing approximately 5.64% of the company's total issued shares [1] Shareholder Activity - Following the sale, Mr. Tan's total shareholding decreased from 23.92 million shares (approximately 20.76% of total issued shares) to 17.42 million shares (approximately 15.12% of total issued shares) [1] - As of the announcement date, Mr. Tan remains a major shareholder of the company [1] Impact on Business - The company believes that this sale will not have a significant impact on its business operations and financial condition [1]

Core Viewpoint - The major shareholder of Lihigh Holdings, Mr. Tan Weitang, has sold a total of 6.5 million shares, representing approximately 5.64% of the company's issued shares, but this sale is not expected to significantly impact the company's operations or financial status [1] Group 1 - Mr. Tan's shareholding decreased from 23.92 million shares (approximately 20.76% of total issued shares) to 17.42 million shares (approximately 15.12% of total issued shares) following the sale [1] - The sale occurred on September 16 and 22, 2025, through public market transactions [1] - As of the announcement date, Mr. Tan remains a major shareholder of the company [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負責，對其準 確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因 倚賴該等內容而引致的任何損失承擔任何責任。 Lapco Holdings Limited ⽴⾼控股有限公司 （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） 本公司認為，此次出售不會對本集團的業務營運及財務狀況產生重大影響。 承董事會命 ⽴⾼控股有限公司 執行董事 譚耀誠 （股份代號：8472） 香港，二零二五年九月二十五日 ⾃願公告 主要股東出售股份 於本公告日期，董事會包括三名執行董事，即譚耀誠先生、周潤璋先生及劉晶晶女士；及 三名獨立非執行董事，即麥國基先生、梁嘉偉先生及翟志勝先生。 本公告乃由立高控股有限公司（「本公司」，連同其附屬公司統稱為「本集團」） 按自願基準作出。 本公司已獲知，本公司主要股東譚偉棠先生（「譚先生」）於二零二五年九月十 六日及二十二日通過公開市場交易出售合共6,500,000股本公司股份（「股份」） （「出售」），佔本公司已發行股份總數約 5.64% 。緊隨出售事項後，譚先生所 持股份總數由 23,92 ...

Core Points - The company announced the appointment of Zhai Zhisheng as an independent non-executive director and chairman of the audit committee, effective from September 8, 2025 [1] Group 1 - Zhai Zhisheng's role will enhance the governance structure of the company [1]